References
- Vedanthan R , SeligmanB, FusterV. Global perspective on acute coronary syndrome: a burden on the young and poor. Circ. Res.114 ( 12 ), 1959 – 1975 (2014).
- Moran AE , ForouzanfarMH, RothGAet al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease study. Circulation129 ( 14 ), 1493 – 1501 (2014).
- Ribeiro AL , DuncanBB, BrantLCC, LotufoPA, MillJG, BarretoSM. Cardiovascular health in Brazil: trends and perspectives. Circulation133 ( 4 ), 422 – 433 (2016).
- Ross R . Atherosclerosis: an inflammatory disease. N. Engl. J. Med.340 ( 2 ), 115 – 126 (1999).
- Libby P , RidkerPM, MaseriA. Inflammation and atherosclerosis. Circulation105 ( 9 ), 1135 – 1143 (2002).
- Hansson GK . Inflammation, atherosclerosis and coronary artery disease. N. Engl. J. Med.352 ( 16 ), 1685 – 1695 (2005).
- Podrez EA , SchmittD, HoffHF, HazenSL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest.103 ( 11 ), 1547 – 1560 (1999).
- Zangh R , BrennanML, FuXet al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA286 ( 17 ), 2136 – 2142 (2001).
- Vita JA , BrennanML, GokceNet al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation110 ( 1134 ), 39 (2004).
- Baldus S , HeeschenC, MeinertzTet al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation108 ( 12 ), 1440 – 1445 (2003).
- Brennan ML , PennMS, LenteFVet al. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med.349 ( 17 ), 1595 – 1604 (2003).
- Mocatta TJ , PilbrowAP, CameronVAet al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J. Am. Coll. Cardiol.49 ( 20 ), 1993 – 2000 (2007).
- Heslop CL , FrohlichJJ, HillJSet al. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J. Am. Coll. Cardiol.55 ( 11 ), 1102 – 1109 (2010).
- Stolic RV , TrajkovicGZ, KosticMet al. Predictive value of serum myeloperoxidase activity for thrombosis of arteriovenous fistulas. Hemodial. Int.18 ( 3 ), 680 – 685 (2014).
- Boudjeltia KZ , DelporteC, AntwerpenPVet al. Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men. Mediators Inflamm.2013, 750742 (2013).
- Zhang T , ShanK, TuXet al. Myeloperoxidase activity and its corresponding mRNA expression as well as gene polymorphism in the population living in the coal-burning endemic fluorosis area in Guizhou of China. Biol. Trace Elem. Res.152 ( 3 ), 379 – 386 (2013).
- Garça MF , AslanM, TunaB, KozanA, CankayaH. Serum myeloperoxidase activity, total antioxidant capacity and nitric oxide levels in patients with chronic otitis media. J. Membr. Biol.246 ( 7 ), 519 – 524 (2013).
- Karahocagil MK , AslanM, CeylanMRet al. Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis. Clin. Biochem.45 ( 10–11 ), 733 – 736 (2012).
- Goulart AC , SantosIS, SitnikDet al. Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). Clinics68 ( 3 ), 431 – 434 (2013).
- Prefeitura do Munícipio de São Paulo . Dados demográficos dos distritos pertencentes as subprefeituras (2012). http://www.prefeitura.sp.gov.br/cidade/secretarias/subprefeituras/subprefeituras/dados demograficos/index.php?p=12758.
- Prefeitura do Município de São Paulo . Butantã, Região Oeste, Sumário de Dados 2004.1-11 (2015). https://www.prefeitura.sp.gov.br/cidade/secretarias/subprefeituras/butanta/.
- Fox KA , GoodmanSG, KleinWet al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur. Heart J.23 ( 15 ), 1177 – 1189 (2002).
- Luepker RV , AppleFS, ChristensonRHet al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation108 ( 20 ), 2543 – 2549 (2003) ( Epub ahead of print).
- Thygesen K , JosephS, HarveyDet al. White on behalf on the joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur. Heart J.28 ( 20 ), 2525 – 2538 (2007).
- Kubala L , LuG, BaldusS, BerglundL, EiserichJP. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin. Chim. Acta394 ( 1–2 ), 59 – 62 (2008).
- Lucio EA , GonçalvesSC, RibeiroJPet al. Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome. Inflamm. Res.60 ( 2 ), 137 – 142 (2011).
- Chapman ALP , MocattaTJ, ShivaSet al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J. Biol. Chem.288 ( 9 ), 6465 – 6477 (2013).
- Podrez EA , Abu-SoudHM, HazenSL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med.28 ( 12 ), 1717 – 1725 (2000).
- Klinke A , NussbaumC, KubalaLet al. Myeloperoxidase attracts neutrophils by physical forces. Blood117 ( 4 ), 1350 – 1358 (2011).
- Zhou T , ZhouSH, QiSS, ShenXQ, ZengGF, ZhouHN. The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. Clin. Chim. Acta368 ( 1–2 ), 168 – 172 (2006).
- Rudolph TK , RudolphV, BaldusS. Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc. Am. Thorac. Soc.5 ( 8 ), 820 – 823 (2008).
- Goldmann BU , RudolphV, RudolphTKet al. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radic. Biol. Med.47 ( 1 ), 79 – 83 (2009).
- Santos IS , GoulartAC, BrandãoRMet al. One-year mortality after an acute coronary event and its clinical predictors: the ERICO study. Arq. Bras. Cardiol.105 ( 1 ), 53 – 64 (2015).
- Chang PY , WuTL, HungCCet al. Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation. Clin. Chim. Acta373 ( 1 ), 158 – 163 (2006).